Pay in 4 interest-free payments of $5.32 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Who should avoid these injections
Degraded GHK-Cu = less active peptide than the label suggests
Multiple cycles with appropriate breaks often outperform single extended cycles for significant fat loss goals
The molecule was developed by the Australian pharmaceutical company Metabolic Pharmaceuticals (in collaboration with Monash University) and advanced through Phase I safety trials and a Phase IIb obesity efficacy trial enrolling approximately 900 participants in total
Licensed Peptides emphasizes documentation, traceability, and supplier accountability to help researchers make informed sourcing decisions and maintain consistent procurement records across projects
US$ 27.30
US$ 26.63
.webp)
US$ 20.66
US$ 27.57
US$ 24.99
US$ 21.54
US$ 26.97
US$ 20.23
